OTLK — Outlook Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Outlook Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	12.5	14.5	17.4	23.4	14.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17.9	21.5	27.5	31	27.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.494	0.275	0.07	0.026	0.275
Long Term Investments
Other Long Term Assets
Total Assets	19.7	22.8	28.5	32.3	28.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.9	6.75	19.7	46.7	42.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16.9	18.2	19.8	46.7	102
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.83	4.61	8.74	-14.4	-73.1
Total Liabilities & Shareholders' Equity	19.7	22.8	28.5	32.3	28.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding